Related Experiment Videos
An epitope delivery system for use with recombinant mycobacteria
1Department of Biology, Imperial College School of Medicine, London, United Kingdom.
Infection and Immunity
|July 23, 1998
Summary
Researchers created a new system to deliver vaccine epitopes using bacteria. This method successfully expressed foreign peptides in mycobacterial vaccine strains, showing potential for improved vaccine delivery vehicles.
Area of Science:
- Microbiology
- Immunology
- Biotechnology
Background:
- Mycobacteria, such as Mycobacterium bovis bacille Calmette-Guérin (BCG) and Mycobacterium vaccae, are established vaccine delivery vehicles.
- Developing effective delivery systems for heterologous peptides is crucial for enhancing vaccine immunogenicity.
Purpose of the Study:
- To develop and characterize a novel epitope delivery system using a bacterial superoxide dismutase scaffold.
- To assess the expression and immunogenicity of heterologous peptide epitopes within mycobacterial vaccine strains.
Main Methods:
- Engineered a novel expression system by inserting peptides into a permissive loop of a bacterial superoxide dismutase.
- Constructed and expressed peptide epitopes from infectious agents and allergens in *Mycobacterium vaccae* and *Mycobacterium bovis* BCG.
- Characterized the immunogenicity of a *M. vaccae* construct expressing a Der p1 house dust mite allergen epitope in T-cell hybridomas and naive mice.
Main Results:
- Achieved high-level expression of heterologous peptides in *M. bovis* BCG and *M. vaccae*.
- Demonstrated that the *M. vaccae*-Der p1 construct stimulated Der p1-specific T-cell hybridomas.
- Induced peptide-specific gamma interferon responses in naive mice immunized with the *M. vaccae*-Der p1 construct.
Conclusions:
- The novel epitope delivery system enables high-level expression of foreign peptides in mycobacteria.
- This system expands the utility of mycobacteria as versatile vaccine delivery vehicles.
- The demonstrated immunogenicity of the Der p1 epitope highlights the potential for developing novel vaccines against allergens and infectious diseases.